1 National Institute of Health Research (NIHR) Cambridge Biomedical Research Centre and the NIHR Blood and Transplant Research Unit (BTRU) at the University of Cambridge in collaboration with Newcastle University and in partnership with National Health Service Blood and Transplant (NHSBT), Cambridge, United Kingdom. 2 NHS Blood and Transplant, Fox Den Road, Bristol, United Kingdom. 3 Liver Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom.
Transplantation. 2017 Jul;101(7):1679-1689. doi: 10.1097/TP.0000000000001727.
Deceased organ donors are routinely screened for behaviors that increase the risk of transmissible blood-borne viral (BBV) infection, but the impact of this information on organ donation and transplant outcome is not well documented. Our aim was to establish the impact of such behavior on organ donation and utilization, as well transplant recipient outcomes.
We identified all UK deceased organ donors from 2003 to 2015 with a disclosed history of increased risk behavior (IRB) including intravenous drug use (IVDU), imprisonment and increased risk sexual behavior.
Of 17 262 potential donors, 659 (3.8%) had IRB for BBV and 285 (1.7%) were seropositive for BBV, of whom half had a history of IRB (mostly IVDU [78.5%]). Of actual donors with IRB, 393 were seronegative for viral markers at time of donation. A history of recent IVDU was associated with fewer potential donors proceeding to become actual organ donors (64% vs 75%, P = 0.007). Donors with IRB provided 1091 organs for transplantation (624 kidneys and 467 other organs). Transplant outcome was similar in recipients of organs from donors with and without IRB. There were 3 cases of unexpected hepatitis C virus transmission, all from an active IVDU donor who was hepatitis C virus seronegative at time of donation, but was found to be viremic on retrospective testing.
Donors with a history of IRB provide a valuable source of organs for transplantation with good transplant outcomes and there is scope for increasing the use of organs from such donors.
常规筛查已故器官捐献者是否存在增加血源性传染病(BBV)感染风险的行为,但这些信息对器官捐献和移植结果的影响尚未得到充分记录。我们的目的是确定此类行为对器官捐献和利用以及移植受者结局的影响。
我们确定了 2003 年至 2015 年期间所有英国已故器官捐献者,这些捐献者的病史显示存在增加 BBV 感染风险的行为(IRB),包括静脉药物使用(IVDU)、监禁和增加风险性行为。
在 17262 名潜在捐献者中,有 659 名(3.8%)有 BBV 感染风险行为史,285 名(1.7%)对 BBV 呈血清阳性,其中一半有 IRB 病史(主要是 IVDU[78.5%])。在有 IRB 的实际捐献者中,393 名在捐献时病毒标志物呈阴性。近期 IVDU 史与潜在捐献者成为实际器官捐献者的比例降低相关(64%比 75%,P=0.007)。有 IRB 的捐献者提供了 1091 个器官用于移植(624 个肾脏和 467 个其他器官)。来自有 IRB 和无 IRB 的捐献者的器官移植受者的结局相似。有 3 例丙型肝炎病毒意外传播,均来自一名活跃的 IVDU 供者,该供者在捐献时丙型肝炎病毒血清学阴性,但在回顾性检测时发现病毒血症。
有 IRB 史的捐献者为移植提供了有价值的器官来源,移植结局良好,有增加使用此类供者器官的空间。